Hepatitis B virus infection: epidemiology and vaccination.

By C. Shepard, Edgar P. Simard, L. Finelli, A. Fiore, B. Bell. Epidemiologic Reviews, 2006

1,163 citations recorded by the source corpus.

Subfields: Epidemiology, Hepatology

View Paper: https://www.semanticscholar.org/paper/b662b9f0ce7f5a0d2a873041ce8e9492356e34cb

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. R. Siegel
2. A. Jemal
3. Elizabeth E. Ward

In Hepatology

1. A. Jemal
2. Elizabeth E. Ward

Citations in the corpus

• Long‐term monitoring shows hepatitis B virus resistance to entecavir in nucleoside‐naïve patients is rare through 5 years of therapy (2009, background): “This barrier to resistance likely results from (1) potent suppression of viral replication, because 93%ofpatientsachievedundetectableHBVDNA( 300copies/mL) during this 5-year period, (2) a high genetic barrier to resistance, and (3) impaired replication of the ETVr variants.”
• Cancers with increasing incidence trends in the United States: 1999 through 2008 (2012, background): “Chronic hepatitis B virus (HBV) infection is a risk factor for liver cancer, and the high incidence rates noted among Asians and Pacific Islanders reflect the substantial burden of endemic HBV infection among those born elsewhere who emigrated to the United States.39,40 The increasing incidence tren”